Skip to main content

NIH to Provide Access to Exome Sequencing for Mendelian Diseases

NEW YORK (GenomeWeb News) – The National Heart, Lung, and Blood Institute will provide researchers studying certain Mendelian disorders access to exome sequencing capabilities under a new four-year grant program.

The program will provide sequencing capacity of the Mendelian Disorders Genome Centers, funded by the National Human Genome Research Institute, for researchers who already have collected samples and are seeking genetic variants involved in monogenic diseases of the heart, lungs, and blood, as well as sleep disorders.

According to NHLBI, around 25 million Americans suffer from rare diseases, a vast majority of which are genetically determined and likely caused by single gene mutations. These Resource Access Awards (X01) will provide sequencing capabilities to that show promise in its ability to identify causal genetic variants for Mendelian diseases with exome sequencing.

Besides studying obvious Mendelian traits, the awards also provide an opportunity to discover de novo mutations and to identify causes of some rare diseases that are difficult to diagnose.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.